Creative Life Science Co

Creative Life Science Co Capital Expenditures

The Capital Expenditures (CapEx) of Creative Life Science Co (7837.TWO) as of Oct 28, 2026 is -33.79 M TWD. In the previous year, Capital Expenditures (CapEx) was -187.09 M TWD — a change of -81.94% (higher).

Capital Expenditures

-33.79 MTWD

YoY

-81.94%

Last updated:

Capital Expenditures (CapEx) of Creative Life Science Co is 2024 -33.79 M TWD. Capital Expenditures (CapEx) of Creative Life Science Co was 2023 -187.09 M TWD. It decreases by -81.94% higher compared to the previous year.

The Creative Life Science Co Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2022
-69.03 M TWD
Jan 1, 2023
-187.09 M TWD
Jan 1, 2024
-33.79 M TWD
The Creative Life Science Co Capital Expenditures history
YEARCapital ExpendituresYoY
-33.79 MTWD-81.94%
-187.09 MTWD+171.01%
-69.03 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Creative Life Science Co Stock analysis

What does Creative Life Science Co do? Creative Life Science Co., Ltd. generates revenue through the sales of its own CMP brand products and agency services for international brands. The CMP product line includes storage and carrying culture medium, sterile transport containers, buffers and diluents, identification reagents, and various culture media types. The company acts as an agent for dry powder culture medium, detection reagents, IVD culture medium, and sampling systems. Its primary market is Taiwan, serving pharmaceutical, biotechnology, food, medical diagnosis, environmental monitoring, and academic research sectors. The company also offers testing, inspection, and certification services to complement its product sales. The firm's revenue streams are derived from direct sales of CMP products to customers in regulated industries such as pharmaceuticals and medical diagnostics. International brand agency sales target similar sectors requiring specialized culture media and diagnostic tools. Testing and certification services are provided to clients needing quality assurance in product development and compliance. All services are concentrated within Taiwan's domestic market, with no mention of international distribution channels. CMP brand products are sold to laboratories and production facilities across multiple industries including food safety testing and environmental monitoring. The agency business focuses on supplying IVD culture media and sampling systems to medical and diagnostic institutions. Testing services support clients in meeting regulatory standards for product safety and efficacy. The company's operations remain strictly within Taiwan, with no indication of global market expansion. Creative Life Science Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Creative Life Science Co stock

Capital Expenditures (CapEx) of Creative Life Science Co is -33.79 M TWD in 2024.

Capital Expenditures (CapEx) of Creative Life Science Co changed from -187.09 M TWD to -33.79 M TWD, representing a -81.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) Creative Life Science Co since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s Creative Life Science Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Creative Life Science Co

All Key Metrics — Creative Life Science Co